Residency Program Director
Holli Winters, PharmD, BCPS
- Specialty Practice Pharmacist, Comprehensive Transplant Center
- Solid Organ Transplant Residency Director, Department of Pharmacy The Ohio State University Wexner Medical Center
- PharmD- University of Cincinnati College of Pharmacy
- PGY1- The Ohio State University Wexner Medical Center
- PGY2 in Internal Medicine- The Ohio State University Wexner Medical Center
Previous Year Residents
Abbie LeinoResearch Fellow- University of Cincinnati
Teresamari Pastrana-CamachoTransplant Clinical Pharmacy Specialist, Memorial Regional Hospital
About the PGY2 Solid Organ Transplant Residency Program
The purpose of the Solid Organ Transplant PGY2 Residency at The Ohio State University Wexner Medical Center is to train pharmacists to become specialists in the area of transplantation so they can work independently in an inpatient, outpatient, or academic setting after graduation. The program is designed to develop the resident’s clinical expertise in abdominal and cardiothoracic transplantation, and additionally provide opportunities for teaching, research, and quality improvement.
As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education and patient care. OSUWMC is a 1350 bed multi-hospital delivery system recognized in 2015 as one of “Americas Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.Read about the sites
University Hospital (UH)
University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the primary burn center for the region. The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer.
OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014. With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new critical care tower.
The Ross Heart Hospital
The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 172-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.
University Hospitals East (UHE)
University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing.
In addition, the OSUWMC also boasts Harding Hospital, which offers comprehensive inpatient and outpatient mental and behavioral health services in addition to Dodd Hall which is a nationally recognized and accredited rehabilitation program specializing in stroke, brain and spinal cord rehabilitation.
The Brain and Spine Hospital
The Brain and Spine Hospital will open in Fall 2016 and be a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital will consist of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.
The Department of Pharmacy
The Department of Pharmacy at The OSUWMC is one of the largest in the country. With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems.
We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship. Training future generations of pharmacists is a vital part of our mission.
Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students. Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities. The Department of Pharmacy, in partnership with the Ohio State College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and excellence of its graduates.
Patient care training is the backbone of this residency experience. The practice site is The Ohio State University Wexner Medical Center Health-System including University Hospital, the Ross Heart Hospital, and the outpatient transplant clinic.
This PGY2 residency is designed to develop clinical skills in the area of adult solid organ transplantation. Approximately 300 patients receive solid organ transplants (kidney, kidney/pancreas, liver, lung, or heart) at OSUWMC each year.
Solid organ transplant patients are admitted to various transplant services throughout the hospital: 1) Transplant Surgery/Renal (all kidney transplant patients who are one year or less from transplant); 2) Transplant Surgery/Other (all kidney/pancreas, isolated pancreas, and liver transplant patients who are one year or less from transplant); 3) Congestive Heart Failure/Open Heart Surgery (all heart and lung transplants); and 4) Transplant Medicine (all kidney, pancreas, and liver transplant patients who are greater than one year post- transplant); and Hepatology (all liver transplant patients who are greater than one year post-transplant). The residency focuses primarily on abdominal transplant.
Elective rotations may include cardiothoracic transplantation, nephrology, hepatology, and transplant infectious disease. The resident will also complete a longitudinal rotation in the outpatient post-transplant clinics, assist in precepting pharmacy students and residents, and participate on various multi-disciplinary committees within the Comprehensive Transplant Center.
The opportunity exists to deliver a didactic lecture at The Ohio State University College of Pharmacy and to earn a formal teaching certificate. The resident will be expected to complete and publish at least one major research project. The program is intended to be flexible and can be modified depending on the individual resident’s interests and needs.
Holli Winters, PharmD, BCPS
Michelle Bradley, PharmD, BCPS
Kevin Kissling, PharmD, BCPS
Pamela Burcham, PharmD, BCPS
Selected Resident Research
- Infectious Complications with Plasmapheresis in Combination with Antithymocyte Globulin for the Treatment of Acute Rejeciton in Renal Transplantation
Leino A, Hulbert A, Lehman A, Rajab A, Von Visger J, Winters H
Presented at the American Transplant Congress 2015; submitted for publication
- Incidence of Cytomegalovirus and Acute Rejection in D+/R- Kidney Transplant Patients on Valganciclovir Prophylaxis after Medication Dose Adjustments
D’Agostino C, Delahunty A, Henry M, Theodoropoulos N, Abdel-Rasoul M, Winters H. Presented at the World Transplant Congress July 2014
- The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients. – Hulbert AL, Delahunty AJ, Rajab A, Forbes RC, Winters H. Clinical Transplant:27(4):E521-E527, 2013.
Benefits and Additional Requirements
Application Deadline: January 6, 2017
Start Date: July 1, 2017
Annual Salary- $47,500
Vacation Days- 10 days
Staffing Requirement- 20 weekends per year
Completion of a Major Research Project